Replies to post #4473 on Applied DNA Sciences Inc (APDN)

[imperativity]

so lets hope the story is that they have gone all in on promoting their product, and they are about to be dealt a winning hand while sitting at the table with some big bucks players!

Exactly. This is why I could overlook the dark secrets the filings contained throughout the years. A company can literally look like a steaming pile of excrement for decades working towards a noble goal, novel drug compound, you name it. It just takes that one break and it'll all be forgotten with revenues and exponential demand.

[timorr]

regarding the net loss . You really have to look at this like a small cap biotech . A small cap biotech spends somewhere near 500 Million dollars just to get the drug through 3rd phase trials not counting the cost of developing the drug . They beg , borrow and steal every cent they can . If it fails , odds are they go belly up , if they pass , maybe they'll do O.K. . This company spent lots on developing the product . The Government testing and acceptance acted as a 3rd phase FDA approval , so yes , tons of money spent without seeing returns but this is like a biotech with a approved drug with orphan drug status. We have done the hard part and now we were awarded a monopoly . Lets all stick around for the pay day this company has earned by hard work. A little patience will pay off in multiples.

[cattracker1]

Agreed,,,,,,,, This Is What We Need !!

The Mandate will put APDN in the BLACK............

:)

[rifmemory]

2020,
Raw numbers (losses) can sometimes look troubling. Losses must be being covered by dilution (JMHO).
I do like the revenues (.5 million in 2010, 1 million in 2011, at least 2 million in 2012).
For the next 4 quarters APDN really needs revenues to double every qtr.[qtr one 1 million, qtr two 2 million, qtr three 4 million, qtr four 8 million), then we should certainly see our ten bagger (JMHO).